Cell & Gene Therapy Drug Delivery Devices Market Scope & Volume Analysis with Executive Summary 2030

Jack daniel avatar   
Jack daniel
The Global Cell & Gene Therapy Drug Delivery Devices Market size was valued at around USD 1.27 billion in 2024 and is projected to reach USD 2.32 billion by 2030. Along with this, the market is estima..

Future of Global Cell & Gene Therapy Drug Delivery Devices Market: Key Dynamics, Size & Share Analysis

The Cell & Gene Therapy Drug Delivery Devices Market size was valued at around USD 1.27 billion in 2024 and is projected to reach USD 2.32 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.53% during the forecast period, i.e., 2025-30.

The market is driven primarily by massive funding by numerous leading players in the technological advancements to bring cost-effective therapies & devices, coupled with the increasing number of FDA approvals for cell & gene therapies & clinical trials. Furthermore, the rising number of FDA Approvals of Cell & Gene Therapies and clinical trials to develop new medical products and provide patients with increased therapeutic choices shall also boost the market in the coming years

Top Market Challenges Impacting the Autonomous Global Cell & Gene Therapy Drug Delivery Devices Market Growth

Scalability and Manufacturing Complexity – One of the most significant challenges restricting the growth of the global cell and gene therapy drug delivery devices market is the issue of scalability and manufacturing complexity. As these therapies transition from clinical development to commercial-scale production, manufacturers face major obstacles in expanding processes that are often manual, labor-intensive, and highly customized for individual patients, especially in autologous therapies. The lack of automated, robust bioprocessing tools and the reliance on skilled labor drive up production costs and limit the ability to meet growing global demand. Additionally, maintaining consistent product quality while increasing batch sizes is difficult, and the need for stringent regulatory compliance further complicates scaling efforts. These factors collectively create bottlenecks in production, inflate costs, and ultimately restrict wider patient access to advanced cell and gene therapies.

 Understanding the Core Segments in the Global Cell & Gene Therapy Drug Delivery Devices Market

By Product Type (Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe (Size 1.0 ML, 31-Gauge Needle), (Size 0.5 ML, 22-Gauge Needle)), Pre-Filled Syringe (Size 1.0 ML, 22-26 Gauge Needle), (Size 4.0 ML, 22-26 Gauge Needle)), Infusion Bags (Size 10 ML to 50 ML), (Size 68 ML), (Size 60 ML), (Size Up to 65 ML)), By Technology (Microchip Technology, Nano-Technology, Lipid Nanoparticles), By Commercialized Drugs (Luxturna, Kymriah, Yescarta, Zolgensma, Provenge, Strimvelis), By End-Users (Pharmaceuticals & Biotechnology Company, Academic & Research Institute, Hospitals & Clinics) 

Unlock exclusive insights into the Cell & Gene Therapy Drug Delivery Devices– request your free sample PDF now and explore key trends, growth drivers, and competitive strategies shaping the industry- https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html

Geographical Analysis of the Global Cell & Gene Therapy Drug Delivery Devices Market

By Region

  • North America
  • South America
  • Europe
  • Middle East & Africa
  • Asia-Pacific

 Who Dominates the Autonomous Global Cell & Gene Therapy Drug Delivery Devices Market Insights on Key Industry Players?

Companies are strengthening their presence in the Cell & Gene Therapy Drug Delivery Devices market by adopting strategies such as forming strategic alliances, leveraging AI, entering partnerships, pursuing mergers and acquisitions, expanding into new regions, and introducing innovative products and services.

  • Amgen Inc.
  • Bausch & Lomb Incorporated
  • Becton, Dickinson and Company
  • Bluebird bio Inc.
  • Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
  • Dendreon Pharmaceuticals LLC
  • Helixmith Co. Ltd (ViroMed Co., Ltd)
  • Human Stem Cells Institute
  • Kite Pharma Inc.
  • Kolon TissueGene, Inc.
  • Novartis AG
  • Orchard Therapeutics plc.
  • Pfizer Inc.
  • Renova Therapeutics
  • Spark Therapeutics Inc.
  • uniQure N.V.
  • Vericel Corporation

Tap into future trends and opportunities shaping the Cell & Gene Therapy Drug Delivery Devices Download the complete report: https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

Why Choose This MarkNtel Advisors Research Report

  1. Comprehensive Insights – Offers a 360° view of the market, combining qualitative and quantitative analysis for a deep understanding of trends, drivers, challenges, and opportunities.
  2. Reliable Data Sources – Data is gathered through verified primary and secondary sources, ensuring accuracy and credibility.
  3. Actionable Forecasts – Advanced predictive modeling and time-series analysis provide practical insights to guide strategic decisions and business planning.
  4. Expert Analysis – Insights from industry experts help interpret complex market dynamics, delivering clarity beyond the numbers.
  5. Customized & Strategic Reporting – The report includes detailed charts, graphs, and strategic recommendations tailored to support business growth and investment decisions.
  6. Trusted Methodology – Built on rigorous research principles, including precise sampling, data validation, and forecasting techniques, reflecting the trust businesses place in MarkNtel Advisors.

"This report equips decision-makers with actionable intelligence, enabling them to navigate market complexities with confidence and foresight."

Gain exclusive access to our comprehensive insights on the Future of Cell & Gene Therapy Drug Delivery Devices User, Multiuser, and Enterprise Packs, our research empowers organizations to navigate dynamic market trends effectively.

Select a License That Matches Your Business Requirements with Instant Offer -

https://www.marknteladvisors.com/pricing/cell-gene-therapy-drug-delivery-devices-market.html

 About us:

We are top leading market research company in Noida, India and have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Being one of the most efficient market research companies in India, our specialized team of experienced & efficient market research professionals is capable of grasping every minute and valuable information & data of the market to offer our clients with satisfactory details. Our company has served the biggest market research firms in India at leading positions and is proficient in managing all types of market research projects.

Other reports:

Qatar Oil Field Chemicals Market Research Report: Forecast (2025-2030)

Saudi Arabia Water-soluble Polymers Market Research Report: Forecast (2025-2030)

 Reach Us:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: sales@marknteladvisors.com

Visit our Website: https://www.marknteladvisors.com

We’re always open to sharing insights, exploring ideas. Follow us to stay updated on the latest news and industry trends.

Walang nakitang komento